SCHEMBL743969

SCHEMBL743969

O=C(O)c1cc(-c2ccccc2)nc(-c2nn[nH]n2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRC Q99895 3/20 0.57
GP6 Q9HCN6 1/20 0.51
MCL1 Q07820 1/20 0.48
TP53 P04637 1/20 0.47
ME2 P23368 1/20 0.47
ME1 P48163 1/20 0.47
ME3 Q16798 1/20 0.47
HPGDS O60760 1/20 0.46
KDM4E B2RXH2 2/20 0.45
XDH P47989 2/20 0.45
MAPT P10636 1/20 0.45
FTO Q9C0B1 1/20 0.44
CES1 P23141 1/20 0.44
PTPN1 P18031 1/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
IDO1 P14902 1/20 0.43
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741202 0.85 GAA (0.50) GP6ME2ME1ME3KDM4E
SCHEMBL4259978 0.83 CTRC (0.77) CTRCMCL1TP53KDM4EALDH1A1
SCHEMBL2201113 0.79 GP6 (0.59) GP6HPGDSKDM4ECES1ALDH1A1
SCHEMBL730756 0.77 CTRC (0.55) CTRCMCL1TP53KDM4EALDH1A1
SCHEMBL940146 0.76 GP6 (0.65) GP6HPGDSKDM4EXDHMAPT
SCHEMBL8783974 0.76 ALDH1A1 (0.51) GP6HPGDSALDH1A1MEN1KMT2A
SCHEMBL12203131 0.75 XDH (0.53) GP6HPGDSXDHMAPTFTO
SCHEMBL7675313 0.74 CTRC (0.63) CTRCMCL1TP53KDM4EALDH1A1
SCHEMBL12203132 0.73 ADH5 (0.63) GP6TP53XDH
SCHEMBL10917470 0.73 CTRC (1.00) CTRCMCL1KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 CTRC 1990/4885GP6 3664/4885MCL1 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.